Skip to main content
SpringerLink
Log in

Primary Pulmonary Hypertension

  • Chapter
Book cover Pulmonary Arterial Hypertension and Interstitial Lung Diseases

  • 1038 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S–12S.

    Article  PubMed  Google Scholar 

  2. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216–223.

    CAS  PubMed  Google Scholar 

  3. Rubin LJ. Primary pulmonary hypertension (review). N Engl J Med 1997;336:111–117.

    Article  CAS  PubMed  Google Scholar 

  4. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Bégaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996:335;609–616.

    Article  CAS  PubMed  Google Scholar 

  5. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection Chest 1991;100:1268–1271.

    Article  CAS  PubMed  Google Scholar 

  6. Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000;9:338–342.

    Article  CAS  PubMed  Google Scholar 

  7. Humbert M, Sitbon O, Chaouat Ari, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France. Registry from a national Registry. J Respir Crit Care Med 2006;173:1023–1030.

    Article  Google Scholar 

  8. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997:337; 581–588.

    Article  CAS  PubMed  Google Scholar 

  9. Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, Dahl CP, Pedersen TM, Ueland T, Gullestad L, Brosstad FR, Aukrust P, Damås JK. Raised LIGHT levels in pulmonary artery hypertension. Am J Respir Crit Care Med 2008;177:202–207.

    Article  CAS  PubMed  Google Scholar 

  10. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1884;70:580–587.

    Google Scholar 

  11. Sitbon O. Prevalence of HIV-related pulmonary artery hypertension in the current antiretro-viral therapy era. Am J Respir Crit Care Med 2008;177:108–113.

    Article  PubMed  Google Scholar 

  12. Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989–993.

    Article  CAS  PubMed  Google Scholar 

  13. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344–350.

    Article  PubMed  Google Scholar 

  14. Kanemoto N, Sasamoto H. Pulmonary hemodynamics in primary pulmonary hypertension. Jpn Heart J 1979;20:395–405.

    CAS  PubMed  Google Scholar 

  15. Eysmann SB, Palevsky HI, Reichek N, Hackney K, Douglas PS. Two dimensional and Doppler-echocardiographic correlates of survival in primary pulmonary hypertension. Circulation 1989;80:353–360.

    CAS  PubMed  Google Scholar 

  16. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992;35:765–770.

    Article  CAS  PubMed  Google Scholar 

  17. Nagaya N, Ando M, Oya H, Ohkita Y, Kyotani S, Sakamaki F, Nakanishi N. Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterec-tomy. Ann Thorac Surg 2002;74:180–184.

    Article  PubMed  Google Scholar 

  18. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001;120:1562–1569.

    Article  CAS  PubMed  Google Scholar 

  19. Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, Yamagishi M, Kunieda T, Miyatake K. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999;160:487–492.

    CAS  PubMed  Google Scholar 

  20. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, Newman J, Wheeler L, Higenbottam T, Gibbs JS, Egan J, Crozier A, Peacock A, Allcock R, Corris P, Loyd JE, Trembath RC, Nichols WC. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741–745.

    Article  CAS  PubMed  Google Scholar 

  21. Goodman DJ, Harrison DC, Popp RL. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol 1974;33:438–443.

    Article  CAS  PubMed  Google Scholar 

  22. Moser KM, Page GT, Ashburn WL, Fedullo PF. Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography. West J Med 1988;148:167–170.

    CAS  PubMed  Google Scholar 

  23. Child JS, Wolfe JD, Tashkin D, Nakano R. Fatal lung scan in a case of pulmonary hypertension due to obliterative pulmonary vascular disease. Chest 1975;67:308–310.

    Article  CAS  PubMed  Google Scholar 

  24. Rubin LJ. Primary pulmonary hypertension: ACCP consensus statement. Chest 1993;104: 236–250.

    Article  CAS  PubMed  Google Scholar 

  25. Badesch DB, Abman SH, Ahearn GS, et al. American College of Chest Physicians. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1 Suppl):35S–62S.

    Article  PubMed  Google Scholar 

  26. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917–1928.

    Article  PubMed  Google Scholar 

  27. Wagenvoort CA, Mulder PG. Thrombotic lesions in primary plexigenic arteriopathy. Chest 1993:103;844–849.

    Article  CAS  PubMed  Google Scholar 

  28. Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Histopathology of primary pulmonary hypertension. Circulation 1989;80:1198–206.

    CAS  PubMed  Google Scholar 

  29. Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990;82:841–847.

    CAS  PubMed  Google Scholar 

  30. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76–81.

    Article  CAS  PubMed  Google Scholar 

  31. Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105–3111.

    Article  CAS  PubMed  Google Scholar 

  32. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, et al. A comparison of continuous intravenous epoprostenol (pros-tacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996:334;296–302.

    Article  CAS  PubMed  Google Scholar 

  33. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G.Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780–788.

    Article  CAS  PubMed  Google Scholar 

  34. McLaughlin V V, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106:1477–1482.

    Article  CAS  PubMed  Google Scholar 

  35. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G.Bosentan therapy for pulmonary arterial hypertension (erratum in: N Engl J Med 2002;346:1258). N Engl J Med. 2002;21;346:896–903.

    Article  Google Scholar 

  36. Rosentzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 2005;60:1025–1030.

    Google Scholar 

  37. Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006;114:48–54.

    Article  CAS  PubMed  Google Scholar 

  38. Humbert M, Barst RJ, Robbins IM, Channick RN, Galiè N, Boonstra A, Rubin LJ, Horn EM, Manes A, Simonneau G. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.Eur Respir J 2004;24:353–359.

    Article  CAS  PubMed  Google Scholar 

  39. Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, Naeije R, Galie N; STRIDE-2 Study Group. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049–2056.

    Article  CAS  PubMed  Google Scholar 

  40. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenalafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148–2157.

    Article  CAS  PubMed  Google Scholar 

  41. Sandoval J, Barst RJ, Rich S, Rothman A. Atrial septostomy for pulmonary hypertension. In: Rich S, editor. Primary pulmonary hypertension:e summary from the World Symposium on PPH 1998. Available at: http://www.Who.int/ncd/cvd/pph.html

  42. Pasque MK, Trulock EP, Cooper JD, Triantafillou AN, Huddleston CB, Rosenbloom M, Sundaresan S, Cox JL, Patterson GA. Single lung transplantation for pulmonary hypertension. Circulation 1995;92:2252–2258.

    CAS  PubMed  Google Scholar 

  43. 2001 Annual report of U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: transplant data 1991–2000. Department of Health and Human Services, Health Resource and Service Administration Office of Special Programs, Division of transplantation, Rockville, MD; United Network for organ sharing; Richmond VA ; University Renal Research and Education Association, Ann Arbor, MI.

    Google Scholar 

  44. Hertz MI, Taylor DO, Trulock EP, Boucek MM, Mohacsi PJ, Edwards LB, Keck BM. The registry of the International Society for Heart and Lung Transplantation: Nineteenth Official Report. J Heart Lung Transplant 2002;21:950–970.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ivano Cantore for expert technical designer assistance and for help in the production of the figures.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Respiratory Unit, Regional Hospital, Aosta, Italy

    Roberto G. Carbone

  2. Professor of Medicine, Dept. of Internal Medicine, Docent of Respiratory Diseases, DIMI-University of Genoa, Genoa, Italy

    Giovanni Bottino

Authors
  1. Roberto G. Carbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Bottino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

    Robert P. Baughman

  2. Department of Internal Medicine, Regional Hospital, Aosta, Italy

    Roberto G. Carbone  & Giovanni Bottino  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Carbone, R.G., Bottino, G. (2009). Primary Pulmonary Hypertension. In: Baughman, R.P., Carbone, R.G., Bottino, G. (eds) Pulmonary Arterial Hypertension and Interstitial Lung Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-074-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-074-8_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-695-5

  • Online ISBN: 978-1-60327-074-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation